A citation-based method for searching scientific literature

Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009
Times Cited: 83







List of co-cited articles
689 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
David J Gallagher, Mia M Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal Vora, Jasmine Bhatia, Zsofia Stadler, Samson W Fine, Victor Reuter,[...]. Clin Cancer Res 2010
174
39

Prostate cancer progression and survival in BRCA2 mutation carriers.
Laufey Tryggvadóttir, Linda Vidarsdóttir, Tryggvi Thorgeirsson, Jon Gunnlaugur Jonasson, Elinborg Jona Olafsdóttir, Gudridur Helga Olafsdóttir, Thorunn Rafnar, Steinunn Thorlacius, Eirikur Jonsson, Jorunn Erla Eyfjord,[...]. J Natl Cancer Inst 2007
147
34

Germline BRCA1 mutations increase prostate cancer risk.
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien,[...]. Br J Cancer 2012
175
33

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
394
32

Rapid progression of prostate cancer in men with a BRCA2 mutation.
S A Narod, S Neuhausen, G Vichodez, S Armel, H T Lynch, P Ghadirian, S Cummings, O Olopade, D Stoppa-Lyonnet, F Couch,[...]. Br J Cancer 2008
97
31


BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Tomas Kirchhoff, Noah D Kauff, Nandita Mitra, Kedoudja Nafa, Helen Huang, Crystal Palmer, Tony Gulati, Eve Wadsworth, Sheri Donat, Mark E Robson,[...]. Clin Cancer Res 2004
107
30

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
I Agalliu, E Karlins, E M Kwon, L M Iwasaki, A Diamond, E A Ostrander, J L Stanford. Br J Cancer 2007
71
32

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
699
26

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
A Mitra, C Fisher, C S Foster, C Jameson, Y Barbachanno, J Bartlett, E Bancroft, R Doherty, Z Kote-Jarai, S Peock,[...]. Br J Cancer 2008
99
24

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
24

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
267
22

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate, Rashmi Singh, Alison Falconer,[...]. Am J Hum Genet 2003
252
22

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
Z Kote-Jarai, D Leongamornlert, E Saunders, M Tymrakiewicz, E Castro, N Mahmud, M Guy, S Edwards, L O'Brien, E Sawyer,[...]. Br J Cancer 2011
229
22

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
728
21


Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
267
21

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
R M Giusti, J L Rutter, P H Duray, L S Freedman, M Konichezky, J Fisher-Fischbein, M H Greene, B Maslansky, A Fischbein, S B Gruber,[...]. J Med Genet 2003
64
26

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
S M Edwards, D G R Evans, Q Hope, A R Norman, Y Barbachano, S Bullock, Z Kote-Jarai, J Meitz, A Falconer, P Osin,[...]. Br J Cancer 2010
104
20

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
77
22

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014
155
20

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
371
19

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
16

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
A Moran, C O'Hara, S Khan, L Shack, E Woodward, E R Maher, F Lalloo, D G R Evans. Fam Cancer 2012
165
16

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.
M R Akbari, C J D Wallis, A Toi, J Trachtenberg, P Sun, S A Narod, R K Nam. Br J Cancer 2014
49
28

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.
Elena Castro, Chee Goh, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Steve Ellis, Debra Frost,[...]. Eur Urol 2015
176
16

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
15

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
15

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
163
15


Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
447
13

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
13

Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.
Shae Ryan, Mark A Jenkins, Aung Ko Win. Cancer Epidemiol Biomarkers Prev 2014
72
15

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
K L Nastiuk, M Mansukhani, M B Terry, P Kularatne, M A Rubin, J Melamed, M D Gammon, M Ittmann, J J Krolewski. Prostate 1999
51
19

A common variant associated with prostate cancer in European and African populations.
Laufey T Amundadottir, Patrick Sulem, Julius Gudmundsson, Agnar Helgason, Adam Baker, Bjarni A Agnarsson, Asgeir Sigurdsson, Kristrun R Benediktsdottir, Jean-Baptiste Cazier, Jesus Sainz,[...]. Nat Genet 2006
576
12

Mendelian inheritance of familial prostate cancer.
B S Carter, T H Beaty, G D Steinberg, B Childs, P C Walsh. Proc Natl Acad Sci U S A 1992
535
12

BRCA2 mutation in Icelandic prostate cancer patients.
S Sigurdsson, S Thorlacius, J Tomasson, L Tryggvadottir, K Benediktsdottir, J E Eyfjörd, E Jonsson. J Mol Med (Berl) 1997
100
10

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
10

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
A Hubert, T Peretz, O Manor, L Kaduri, N Wienberg, I Lerer, M Sagi, D Abeliovich. Am J Hum Genet 1999
51
17

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
10

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
10

Screening and prostate-cancer mortality in a randomized European study.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa,[...]. N Engl J Med 2009
10

Multiple newly identified loci associated with prostate cancer susceptibility.
Rosalind A Eeles, Zsofia Kote-Jarai, Graham G Giles, Ali Amin Al Olama, Michelle Guy, Sarah K Jugurnauth, Shani Mulholland, Daniel A Leongamornlert, Stephen M Edwards, Jonathan Morrison,[...]. Nat Genet 2008
637
10

The heritability of prostate cancer in the Nordic Twin Study of Cancer.
Jacob B Hjelmborg, Thomas Scheike, Klaus Holst, Axel Skytthe, Kathryn L Penney, Rebecca E Graff, Eero Pukkala, Kaare Christensen, Hans-Olov Adami, Niels V Holm,[...]. Cancer Epidemiol Biomarkers Prev 2014
104
10

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
126
10

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
A Vazina, J Baniel, Y Yaacobi, A Shtriker, D Engelstein, I Leibovitz, M Zehavi, A A Sidi, Y Ramon, T Tischler,[...]. Br J Cancer 2000
42
19


Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
Anita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, Elizabeth C Page, C S Foster, C Jameson, G Mitchell, G J Lindeman, A Stapleton, G Suthers,[...]. BJU Int 2011
68
11

Mortality results from a randomized prostate-cancer screening trial.
Gerald L Andriole, E David Crawford, Robert L Grubb, Saundra S Buys, David Chia, Timothy R Church, Mona N Fouad, Edward P Gelmann, Paul A Kvale, Douglas J Reding,[...]. N Engl J Med 2009
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.